Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
936.35
-6.20 (-0.66%) Zydus Lifesciences - Quaterly Results
Date: 20-05-2022
The total revenue for the quarter ended March 2022 remained nearly unchanged at Rs. 20193.00 millions.Net profit of the cmpany stood at Rs. 2469.00 millions for the quarter ended March 2022 a decline of -46.87% from Rs. 4647.00 millions in the same quarter last year.The company reported a degrowth in operating Profit to 5113.00 millions from 5773.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202203 | 202103 | % Var | 202203 | 202103 | % Var | 202203 | 202103 | % Var | |
| Sales | 20193.00 | 20084.00 | 0.54 | 79819.00 | 77800.00 | 2.60 | 79819.00 | 77800.00 | 2.60 |
| Other Income | 537.00 | -165.00 | -425.45 | 1787.00 | 893.00 | 100.11 | 1787.00 | 893.00 | 100.11 |
| PBIDT | 5113.00 | 5773.00 | -11.43 | 20968.00 | 23980.00 | -12.56 | 20968.00 | 23980.00 | -12.56 |
| Interest | 420.00 | 205.00 | 104.88 | 1349.00 | 709.00 | 90.27 | 1349.00 | 709.00 | 90.27 |
| PBDT | 4693.00 | 5568.00 | -15.71 | 16426.00 | 21396.00 | -23.23 | 16426.00 | 21396.00 | -23.23 |
| Depreciation | 1228.00 | 1150.00 | 6.78 | 4787.00 | 4511.00 | 6.12 | 4787.00 | 4511.00 | 6.12 |
| PBT | 3465.00 | 4418.00 | -21.57 | 11639.00 | 16885.00 | -31.07 | 11639.00 | 16885.00 | -31.07 |
| TAX | 996.00 | -229.00 | -534.93 | 3060.00 | 2123.00 | 44.14 | 3060.00 | 2123.00 | 44.14 |
| Deferred Tax | 217.00 | -784.00 | -127.68 | 458.00 | -910.00 | -150.33 | 458.00 | -910.00 | -150.33 |
| PAT | 2469.00 | 4647.00 | -46.87 | 8579.00 | 14762.00 | -41.88 | 8579.00 | 14762.00 | -41.88 |
| Equity | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 |
| PBIDTM(%) | 25.32 | 28.74 | -11.91 | 26.27 | 30.82 | -14.77 | 26.27 | 30.82 | -14.77 |